SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-330646
Filing Date
2020-12-31
Accepted
2020-12-31 17:28:32
Documents
16
Period of Report
2020-12-31
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d19127d8k.htm   iXBRL 8-K 29187
2 EX-5.1 d19127dex51.htm EX-5.1 7763
3 EX-1.1 d19127dex11.htm EX-1.1 168998
7 GRAPHIC g19127g0101003126862.jpg GRAPHIC 2532
8 GRAPHIC g19127g0101003127064.jpg GRAPHIC 2571
  Complete submission text file 0001193125-20-330646.txt   393259

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA krys-20201231.xsd EX-101.SCH 3074
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE krys-20201231_lab.xml EX-101.LAB 18886
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE krys-20201231_pre.xml EX-101.PRE 11862
9 EXTRACTED XBRL INSTANCE DOCUMENT d19127d8k_htm.xml XML 3446
Mailing Address 2100 WHARTON STREET SUITE 701 PITTSBURGH PA 15203
Business Address 2100 WHARTON STREET SUITE 701 PITTSBURGH PA 15203 (412) 586-5830
Krystal Biotech, Inc. (Filer) CIK: 0001711279 (see all company filings)

IRS No.: 821080209 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38210 | Film No.: 201429521
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences